FDA Peptide Panel’s New Members? A Cautionary Look
Posted by amber464 in Research & News - 1 points, 0 comments.
The PBS article reports that the FDA is forming a new advisory panel on peptide drugs, and the panel will include experts who champion unproven peptides favored by RFK Jr. The piece highlights concerns about conflicts of interest and the political pressure to loosen restrictions.
I’m not surprised, but I’m alarmed. In my own N‑1 experiments with peptides, the outcomes have been mild and highly variable; I’ve never seen a single dramatic health transformation. The panel’s tilt toward hype feels like a recipe for flooding the market with risky, unvalidated products. As someone who tracks HRV and liver enzymes, I worry this could undermine the careful checks that keep our protocols safe. The article leaves out how the panel’s recommendations will be vetted, will they actually push for stricter FDA scrutiny or just more leniency?
Question: Will the panel’s political leanings push the FDA toward easing restrictions, or will they end up tightening oversight to protect consumers? What do you think will happen next?
Community discussion - research and educational context only. Not medical advice.